Approval · Notice of Compliance 28093 · 2022
DRAXIMAGE MDP: Notice of Compliance 28093
Issued May 4, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28093
- Date
- May 4, 2022
- Company
- Jubilant Draximage Inc.Kirkland, Quebec, Canada
- Product type
- Radiopharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product Monograph update
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DRAXIMAGE MDP | Not yet assigned | — |
| DRAXIMAGE MDP-25 | Not yet assigned | — |
Medicinal ingredients
- MEDRONIC ACID 10 MG per VIAL
- MEDRONIC ACID 25 MG per VIAL